相关实验视频
Updated: Jun 21, 2025

05:42
The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
37.3K
托分解的变化与抑郁症多模式治疗的反应有关
Eva Z Reininghaus1, Melanie Lenger1, Elena M D Schönthaler1
1Clinical Division of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
Frontiers in psychiatry
|July 8, 2024
概括
抑郁症治疗反应可能与金氨酸 (KYN) 途径代谢物的变化有关. 没有反应的患者表现出更高的3-氨酸 (3-HAA) 和尼古丁酸 (NA) 水平,这表明这些代谢物是治疗结果的关键.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生化学
- 精神病学是一个精神病学.
背景情况:
- 托 (TRP) 基努林 (KYN) 途径失调与抑郁症有关.
- 之前的研究指出了与治疗反应相关的性别特异性TRP分解和KYN/TRP变化.
- 关于治疗对KYN途径代谢物的影响及其与抑郁症治疗结果的联系的数据有限.
研究的目的:
- 在为期六周的多式模式精神科康复计划中调查KYN途径代谢物的变化.
- 将这些代谢变化与抑郁症患者的治疗反应联系起来.
主要方法:
- 87名参与者 (48名受访者,39名非受访者) 在6周内进行了评估.
- 用高性能液态染色学测量KYN途径代谢物的血清度和比率.
- 用重复测量和 (共) 差分析来计算随时间变化的变化.
主要成果:
- 没有反应的人具有更高的3-氨酸 (3-HAA) 和尼古丁酸 (NA),以及3-HAA/KYN比率.
- 在这两组中,随着时间的推移,NA水平下降,3-HAA水平增加.
- 在不响应者中,KYN水平增加,而3-HK/KYN水平随着时间的推移而下降,但没有响应者.
结论:
- 多模式干预可以改变与抑郁症治疗反应相关的KYN途径代谢物.
- KYN降解途径,特别是涉及3-HAA和3-HK/KYN,对于抑郁症治疗成功至关重要.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
215
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
215
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
358
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
358
Antidepressant Drugs: Overview
430
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
430
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
119
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
119
Depression: Overview
237
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
237
Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K

